StockGlow

iX Biopharma Ltd. (42C.SI)

iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.

0.51+0.01%Healthcare
Compare 42C.SI with
StockGlow Score
94
Bullish
BearishBullish
1 year ago+2584.2%

The outlook

iX Biopharma Ltd. currently reads as bullish based on above its 50- & 200-day averages, 92% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Market cap
$557.6M
52-wk high
0.55
52-wk low
0.02
50-day avg
0.38
200-day avg
0.25
Trailing P/E
0.8

Similar stocks

546.SIMedtecs International Corporation Limited$0.11+0.00%8YY.SIEmbracing Future Holdings Limited$0.04+0.00%1J5.SIHyphens Pharma International Limited$0.35+0.00%1H3.SIClearbridge Health Limited$0.00+0.00%AP4.SIRiverstone Holdings Limited$0.86+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy